The global muscle stimulator market is expected to post steady growth over the next decade, according to a new industry forecast from SNS Insider. The report says the market, valued at USD 812.01 million in 2025, is projected to reach USD 1,156.54 million by 2035.
The outlook points to rising use of neuromuscular electrical stimulation devices as a key factor behind that expansion. These products are used across rehabilitation, recovery, and related care settings, supporting broader demand as healthcare providers and consumers continue adopting device-based therapies.
Regionally, the U.S. market is projected to increase from USD 320.00 million in 2025 to USD 425.90 million by 2035. Europe is also expected to grow during the same period, rising from USD 243.60 million to USD 335.40 million, reflecting continued interest in muscle stimulation technologies across major healthcare markets.
Overall, the forecast suggests a gradual but meaningful rise in market value through 2035. With demand supported by wider use of neuromuscular stimulation solutions, the sector appears positioned for continued expansion in both North America and Europe.